Learn More
Medchemexpress LLC Dota-octreotide tfa | 99.3% | 1519.66 | 1 MG

Supplier: Medchemexpress LLC HYP10273A1MG
DOTA-Octreotide TFA is composed of the chelator DOTA and Octreotide (HY-P0036). It is utilized for cancer research through its combination with radioactive elements and can be employed for the synthesis and research of Radionuclide-Drug Conjugates (RDCs). Its molecular formula is C67H93F3N14O19S2 with a molecular weight of 1519.66. It appears as a white to off-white solid.
- Used for cancer research
- Combines with radioactive elements
- Can be used for synthesis and research of radionuclide-drug conjugates (RDCs)
- Soluble in H2O at ≥ 50 mg/mL (32.90 mM)
- Powder stable for 2 years at -80°C and 1 year at -20°C
- Solution stable for 6 months at -80°C and 1 month at -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.